pharmaphorum

FEBRUARY 22, 2021

As part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of postpartum depression, talks about the power of peer support, and explains what the wider healthcare community could do to play their part. Within days of giving birth to her first child, Jen Schwartz’s fairy tale view of motherhood lay in tatters at the foot of the bed she found it impossible to leave.

Hospitals 120

Hospitals 120

NY Times

FEBRUARY 25, 2021

Many scientists are expecting another rise in infections. But this time the surge will be blunted by vaccines and, hopefully, widespread caution. By summer, Americans may be looking at a return to normal life.

Vaccines 97

Vaccines Immunity Immunization 97

Pharma Times

FEBRUARY 25, 2021

The prestigious Clinical Researcher of the Year – The Americas has now opened its doors for entry, continuing the successes of the 10th anniversary last year.

88

88

Drug Patent Watch

FEBRUARY 25, 2021

Annual Drug Patent Expirations for JORNAY+PM Jornay Pm is a drug marketed by Ironshore Pharms and is included in one NDA. There are eleven patents protecting this drug. JORNAY PM…. The post New patent for Ironshore Pharms drug JORNAY PM appeared first on DrugPatentWatch - Make Better Decisions.

81

81

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 25, 2021

Pfizer/BioNTech’s mRNA vaccine against COVID is a technical marvel – but the ultra-cool temperatures required for storage and stability has been tricky to handle. Maryland, US-based company Altimmune is among the biotechs and research labs trying to find more convenient alternatives and believes a nasal vaccine spray that is stable at room temperature could be the answer.

Vaccines 106

Vaccines Immunity Immunization 106

Outsourcing Pharma

FEBRUARY 25, 2021

An executive from the rare disease technology solutions company discusses how forcing connections with patients can boost research into such conditions.

72

72

NY Times

FEBRUARY 26, 2021

The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.

75

75

pharmaphorum

FEBRUARY 26, 2021

Healthcare organisations that have been traditionally slow to adopt new technology produced a response to the pandemic that was almost in line with less regulated industries, according to a new report. Findings of research from the cloud communications platform Twilio based on 2,500 enterprise decision makers, including 117 healthcare organisations, showed it took 36 days on average to accelerate a digital transformation strategy.

Communication 105

Communication 105

Outsourcing Pharma

FEBRUARY 25, 2021

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

72

72

Pharma Times

FEBRUARY 26, 2021

Edison Accelerator to support start-ups to develop AI applications for healthcare

116

116

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

NY Times

FEBRUARY 24, 2021

President Biden signed an executive order aimed at reducing U.S. reliance on foreign-made products, especially in a national emergency, after a bipartisan meeting with lawmakers.

52

52

pharmaphorum

FEBRUARY 26, 2021

Rare diseases impact between 3.5%-5.9% of the world’s population. For Rare Disease Day, RBW Consulting’s Emma Thorp discusses why the consultancy is taking revenue earned from its rare disease clients and using it to fund research into the mental health impact of a rare disease diagnosis. Rare diseases are often chronic and life-threatening, and with a large percentage of cases presenting in young children, a diagnosis has a profound and unique impact on everyone affected.

Hospitals 98

Hospitals 98

Outsourcing Pharma

FEBRUARY 24, 2021

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine.

Vaccines 68

Vaccines 68

Pharma Times

FEBRUARY 24, 2021

Orphan designation granted for the treatment of retinitis pigmentosa and Leber Congenital amaurosis

98

98

NY Times

FEBRUARY 24, 2021

VaccineFinder.org is an ambitious but limited attempt to simplify Americans’ search for vaccines.

Vaccines 74

Vaccines Immunity Immunization 74

pharmaphorum

FEBRUARY 23, 2021

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer, in non-small cell lung cancer patients whose tumours have high PD-L1 expression brings the drug into competition with Merck & Co’s Keytruda (pembrolizumab), which has become the go-to therapy in this disease.

Chemotherapy 95

Chemotherapy 95

Outsourcing Pharma

FEBRUARY 25, 2021

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

Drug Development 65

Drug Development 65

Pharma Times

FEBRUARY 22, 2021

Services will be offered to staff who have been affected by the COVID-19 pandemic

106

106

Drug Patent Watch

FEBRUARY 26, 2021

Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Sarepta Theraps drug EXONDYS 51 appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 25, 2021

How has rare disease care changed over the last few years? And what might we expect from the next five? We attended the Rare Disease Day Virtual Parliamentary Event to find out. The rare disease community has a golden opportunity to transform the way care is delivered across all four UK nations – that’s according to speakers at a parliamentary reception held to mark 2021’s Rare Disease Day.

Documentation 87

Documentation Labelling 87

Outsourcing Pharma

FEBRUARY 24, 2021

An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.

59

59

Pharma Times

FEBRUARY 23, 2021

Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials

92

92

Drug Patent Watch

FEBRUARY 26, 2021

Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from three suppliers. There are five patents protecting…. The post New patent for Pfizer drug IBRANCE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 25, 2021

To help pharma companies understand what life is really like for patients with a rare disease, a new resource has been released to coincide with Rare Disease Day 2021. A series of stakeholder interviews have been collected in a new video from Bedrock Healthcare Communications and Origins Insights that explores the underappreciated challenges of living with a rare disease.

Communication 85

Communication 85

Outsourcing Pharma

FEBRUARY 23, 2021

The US Food and Drug Administration (FDA) has issued guidance for companies developing vaccines, diagnostics and therapeutics against new variants of SARS-CoV-2.

Vaccines 56

Vaccines 56

Pharma Times

FEBRUARY 22, 2021

Decision made in consultation with the FDA following disappointing trial results

92

92

Drug Patent Watch

FEBRUARY 26, 2021

Annual Drug Patent Expirations for ZOKINVY Zokinvy is a drug marketed by Eiger Biopharms and is included in one NDA. The generic ingredient in ZOKINVY is lonafarnib. Additional details are…. The post New patent for Eiger Biopharms drug ZOKINVY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

FEBRUARY 24, 2021

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Spain. Higher biosimilar savings. Spain, like many European countries, have seen biosimilars as a route to helping manage pressure on health care spending.

Biosimilars 75

Biosimilars Immunity Immunization 75

Pharma Marketing Network

FEBRUARY 26, 2021

Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers to innovation are falling, digital transformation is accelerating, and new cultures in collaboration, and patient-centricity are rapidly growing. The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU

52

52

Pharma Times

FEBRUARY 24, 2021

Over 31,000 women in London to be offered the at-home tests

99

99

Pharma Mirror

FEBRUARY 25, 2021

Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein. Romaco Kilian GmbH in Cologne has acquired a new Sales & Service Director. As of February 2021, Borja Guerra is responsible not only for the Sales & Service department but also for product and project management at the manufacturer of tablet presses for the pharmaceutical

52

52

pharmaphorum

FEBRUARY 26, 2021

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus. UCB completed six months’ worth of computational screening and compound design in three days using the technology.

Compounding 72

Compounding 72

Pharma Marketing Network

FEBRUARY 26, 2021

As markets swell with digital content and HCPs become increasingly time-poor, your customer engagement strategy can no longer be driven by reach and frequency, but by the value added at every interaction and touchpoint. At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs.

52

52

Pharma Times

FEBRUARY 25, 2021

Production site in Måløv, Denmark manufactures products for oral diabetes treatment Rybelsus

Diabetes 83

Diabetes 83

Drug Patent Watch

FEBRUARY 25, 2021

Annual Drug Patent Expirations for ZYKADIA Zykadia is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are twelve patents protecting…. The post New patent expiration for Novartis drug ZYKADIA appeared first on DrugPatentWatch - Make Better Decisions.

52

52